Tumors remove natural killer group 2D (NKG2D) ligands, which is one of the primary mechanisms responsible for subverting NKG2D-mediated immunosurveillance in leukemia stem cells (LSCs)39. The gene discussed is KLRK1; the disease is leukemia.